362 related articles for article (PubMed ID: 15703304)
1. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs.
Yamaji T; Mitsuki M; Teranishi T; Hashimoto Y
Glycobiology; 2005 Jul; 15(7):667-76. PubMed ID: 15703304
[TBL] [Abstract][Full Text] [Related]
2. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
3. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
[TBL] [Abstract][Full Text] [Related]
4. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
Burshtyn DN; Lam AS; Weston M; Gupta N; Warmerdam PA; Long EO
J Immunol; 1999 Jan; 162(2):897-902. PubMed ID: 9916713
[TBL] [Abstract][Full Text] [Related]
5. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
6. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
Avril T; Freeman SD; Attrill H; Clarke RG; Crocker PR
J Biol Chem; 2005 May; 280(20):19843-51. PubMed ID: 15769739
[TBL] [Abstract][Full Text] [Related]
7. The rat orthologue to the inhibitory receptor gp49B is expressed by neutrophils and monocytes, but not by NK cells or mast cells.
Bryceson YT; Torgersen KM; Inngjerdingen M; Berg SF; Hoelsbrekken SE; Fossum S; Dissen E
Eur J Immunol; 2005 Apr; 35(4):1230-9. PubMed ID: 15756648
[TBL] [Abstract][Full Text] [Related]
8. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and characterization of SPAP1, an inhibitory receptor.
Xu MJ; Zhao R; Zhao ZJ
Biochem Biophys Res Commun; 2001 Jan; 280(3):768-75. PubMed ID: 11162587
[TBL] [Abstract][Full Text] [Related]
10. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
[TBL] [Abstract][Full Text] [Related]
11. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase.
Mason LH; Gosselin P; Anderson SK; Fogler WE; Ortaldo JR; McVicar DW
J Immunol; 1997 Nov; 159(9):4187-96. PubMed ID: 9379012
[TBL] [Abstract][Full Text] [Related]
12. Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937.
Mitsuki M; Nara K; Yamaji T; Enomoto A; Kanno M; Yamaguchi Y; Yamada A; Waguri S; Hashimoto Y
Glycobiology; 2010 Mar; 20(3):395-402. PubMed ID: 20032046
[TBL] [Abstract][Full Text] [Related]
13. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail.
Poole AW; Jones ML
Cell Signal; 2005 Nov; 17(11):1323-32. PubMed ID: 16084691
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of S2V, a novel putative siglec that contains two V set Ig-like domains and recruits protein-tyrosine phosphatases SHPs.
Yu Z; Lai CM; Maoui M; Banville D; Shen SH
J Biol Chem; 2001 Jun; 276(26):23816-24. PubMed ID: 11328818
[TBL] [Abstract][Full Text] [Related]
16. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning of MIS, a myeloid inhibitory siglec, that binds protein-tyrosine phosphatases SHP-1 and SHP-2.
Ulyanova T; Shah DD; Thomas ML
J Biol Chem; 2001 Apr; 276(17):14451-8. PubMed ID: 11278955
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of killer cell inhibitory receptor-mediated signal transduction machinery in a cell-free model system.
Cho HI; Park CG; Kim J
Arch Biochem Biophys; 1999 Aug; 368(2):221-31. PubMed ID: 10441372
[TBL] [Abstract][Full Text] [Related]
19. IREM-1 is a novel inhibitory receptor expressed by myeloid cells.
Alvarez-Errico D; Aguilar H; Kitzig F; Brckalo T; Sayós J; López-Botet M
Eur J Immunol; 2004 Dec; 34(12):3690-701. PubMed ID: 15549731
[TBL] [Abstract][Full Text] [Related]
20. Shp-2 tyrosine phosphatase: signaling one cell or many.
Feng GS
Exp Cell Res; 1999 Nov; 253(1):47-54. PubMed ID: 10579910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
